Usama Gergis, MD, presents the case of a 61-year old man with GvHD, and provides an overview of available treatment options for similar patients, with consideration of the REACH1, REACH2, and GRAVITAS-301 trial regimens.
EP. 1: A 61-Year-Old Man With Graft-Versus-Host Disease
Watch
EP. 2: Steroid-Dependent Versus Steroid-Refractory Graft-Versus-Host Disease
EP. 3: Phase 2 REACH1 Overview
EP. 4: REACH1 Regimen: Steroid Combination and Adverse Events
EP. 5: Phase 3 Trials: REACH2 and GRAVITAS-301
EP. 6: The Future of GVHD Management